View Article

  • The Role of Medicinal Herbs in the Management of Metabolic Syndrome: A Comprehensive Review

  • SMBT college of pharmacy Dhamangaon, Nashik.

Abstract

Insulin resistance is the primary etiology of metabolic syndrome, which is defined by diseases such as diabetes, obesity, and hypertension. Increased interest in natural remedies is due to the limitations of conventional treatments, including high expense and adverse effects. This research investigates the therapeutic potential of medicinal herbs like ashwagandha, cinnamon, and ginger in the management of metabolic syndrome. It also stresses the significance of lifestyle factors such as diet and exercise, as well as the customized nature of Ayurvedic therapies.

Keywords

Metabolic Syndrome, Insulin Resistance, Diabetes, Obesity, Hypertension, Medicinal Herb, Natural Remedies, Life Style.

Introduction

Illnesses including cancer, diabetes, bone metabolic disease, fatty liver, obesity, cardiovascular disease, and others are referred to as metabolic illnesses or metabolic syndromes because they are linked to abnormalities in the metabolism of substances like glucose, fat, or protein(1). When three or more of the five criteria are satisfied, metabolic syndrome is diagnosed(2). The primary cause of metabolic syndrome is thought to be insulin resistance. Increased resistance will result in increased insulin secretion and metabolic syndrome. Insulin resistance is typically linked to genetic factors, autonomic hyperactivity, stress, obesity, and decreased physical exercise(3). The metabolic syndrome is a group of metabolic diseases caused by aging, ethnicity, stress, poor nutrition, genetic predisposition, and decreased physical activity. Despite the existence of conventional pharmaceutical treatments for metabolic syndrome, their limited use is ascribed to their high expense and side effects. In order to manage this illness, natural products with less adverse impacts have been studied(4). The purpose of this review of the literature is to investigate how natural products—such as vitamins, minerals, probiotics, botanicals, herbs, and dietary supplements—can help manage metabolic syndrome(5). Changes in a population's metabolic profile that are directly related to their daily routines are known as lifestyle illnesses. Unorganized eating habits, unoccupied exercise activities, etc.(6). are the main causes of lifestyle disorders. As obesity rates rise, metabolic syndrome—a prevalent metabolic condition—becomes worse. According to the WHO, metabolic syndrome, often referred to as syndrome X, insulin resistance, and other names, is a pathologic condition marked by hypertension, hyperlipidemia, abdominal obesity, and insulin resistance(7). Other comorbidities include nonalcoholic fatty liver disease, prothrombotic disorders, proinflammatory states, and reproductive abnormalities(4). Deficits in protein, glucose, lipids, and carbohydrates are among the metabolic diseases that make up the metabolic syndrome (MetS). Atherosclerotic cardiovascular diseases (ASCVD) and type 2 diabetes risk factors are combined to define it. These risk factors cause abnormal cholesterol or triglyceride levels, obesity, extra belly fat, high blood pressure, high blood sugar, or diabetes(8).  Due to its natural origin and fewer side effects, herbal medicines have become increasingly popular in both developed and developing nations, and their area has grown exponentially in the last several years. Numerous conventional medications are made from organic materials, minerals, and medicinal plants(9). The Indian traditional health care system uses herbal preparations that contain a few medicinal herbs known as rasayana, which have been utilized for more than a millennium. In the Indian medical system, the majority of practitioners create and administer their own medications(10). 21,000 plants are listed by the World Health Organization (WHO) as being utilized for medicinal purposes worldwide. 150 of these 2500 species are widely used commercially, with the majority occurring in India. . India is referred to as the world's botanical paradise and is the world's largest producer of medicinal herbs(11).

 

 

 

 

Figure 2. The Metabolic Syndrome

 

Types of metabolic syndrome

There are various types of metabolic syndrome Diabetes, Gaucher disease, Mitochondrial disease, Hypertension, Cholesterol gallstone, Elevated plasma glucose, Obesity, Phenylketonuria(12).

Diabetes

There are two types of diabetes

There are two types of diabetes

Type 1 & Type 2

Diabetes is a long-term metabolic disease that significantly affects sufferers' socioeconomic standing. In certain wealthy nations, The incidence of diabetes has gradually risen throughout the last few decades. Diseases Associated with Lifestyle and Metabolic Syndrome 2. According to research from the International Diabetes Federation (IDF), if effective treatment measures are not put in place, the number of people with diabetes might rise by 693 million by 2045(13). Figure 1 shows the prevalence and incidence of diabetes in Indian communities. Diabetes is becoming a bigger problem in India, according to IDF data. Patients with diabetes range in age from 20 to 70 years, with an estimated 8.7% of them having the disease(14). Formally speaking, diabetes mellitus is a metabolic disease that is associated with the metabolism of proteins, fats, and carbohydrates. Insulin resistance and/or insufficiency are the next symptoms. Weight loss, blurred vision, thirst, and polyuria are the hallmark signs and symptoms of diabetes mellitus. Studies from the past ten years indicate that between 25% and 33% of persons from different ethnic backgrounds fulfill the parameters for the metabolic syndrome. As people age, metabolic syndrome becomes more prevalent(15). It has been demonstrated that certain ethnic groups are more likely to have type 2 diabetes mellitus (T2DM); for example, only 4.30% of Chinese Americans and 15% of American Indians have T2DM. Abdominal obesity and metabolic syndrome are more common in South Asian Americans than in other ethnic groups(16).

 

 

 

 

Figure 1. Rate of diabetes patient in India in millions

 

The prevalence of type 2 diabetes mellitus (T2DM) is increasing, and it has progressively turned into an epidemic that affects public health worldwide(17). By 2045, 783 million adults are predicted to have diabetes, according to new data released by the International Diabetes Federation(18). It is typified by consistently elevated blood sugar levels brought on by insulin resistance or insufficiency. Nowadays, the standard treatment for type 2 diabetes is diet-based, with the addition of insulin injections or oral medications for individuals who are unable to control their blood glucose levels with diet alone(19). Type 1 diabetes mellitus (DM) and Type 2 diabetes mellitus (DM) are the two main forms of the disease. Because the pancreatic β cells have been completely destroyed, type 1 diabetes is characterized by a complete lack of insulin production. This can be acquired or epigenetic (autoimmune/mutation). Just 10% of all diabetes patients are T1DM. Although it affects people of all ages, children under five are most affected. T2DM, which makes up 90% of all DM cases, is defined by a persistent rise in blood glucose levels (chronic hyperglycemia) brought on by a malfunction in either the receptor for insulin (insulin resistance) or the production of insulin (impaired β cell activity)(20).  Gestational diabetes mellitus (GDM) is another mild form of diabetes mellitus that develops during pregnancy because of elevated blood glucose levels. Diabetes frequently manifests as polyuria (increased urination), polyphagia (increased appetite), polydipsia (increased thirst), and weight loss (caused by excessive protein oxidation and glycation)(21).

Obesity

Defend is condition of excessive fat storage, A major public health problem is obesity, affecting about 2 billion people globally(22). Increased healthcare expenses, reduced productivity, and unfavorable social and economic consequences are all caused by obesity. Furthermore, obesity is closely linked to metabolic syndrome, which includes type 2 diabetes, dyslipidemia, hypertension, and cardiovascular disease, according to numerous research. As a result, obesity poses a risk to public health and raises mortality and lowers quality of life. Headache, nausea, dry mouth, and sleeplessness(23). Unfortunately, obesity is still difficult to avoid and manage. Making the right dietary and lifestyle choices has been proposed as the most effective strategy to fight obesity, but long-term lifestyle adjustments are challenging(24). However, it has been noted that including functional foods in the diet can help prevent or treat obesity. Vascular tissues grow as a result of increased cytokine production brought on by the buildup of extra adipocytes. The repercussions of atherosclerosis, cardiovascular abnormalities, and hyperlipidemia are all interrelated. Because obesity increases the risk of several diseases, including colon cancer, gallstones, liver and gut disease, etc., atherosclerosis plays a role in obesity. The prevention and treatment of these co-morbidities can therefore be achieved through the management of obesity(25). Increasing calorie expenditure or decreasing appetite can aid with weight control. The hormones and receptors that control hunger and satiety also control appetite. Sitting less can also lessen the accumulation of white adipose tissue. Consequently, inhibition of adiponectin would be beneficial in preventing carcinogenesis linked to fat. The release of insulin is increased by hormones like cortisol, norepinephrine, and adrenaline(26). Insulin regulates blood glucose levels and body fat. Molecules 2022, 27, 1713 4 of 37? Consequently, any one component of this fundamental physiological cycle is out of balance, leading to obesity. Insulin is linked to diabetes and is crucial in the management of obesity. Dopamine helps the digestive tract and pancreas release their hormones and controls fat. Obesity can result from hormone imbalances, but homeostatic regulation governs the hormones that maintain hunger, satiety, and body fat. Thus, these components and their effects are severe when developing new anti-obesity medications(27).

Table 1. According to (WHO) Classification of weight.

Weight Status

Body Mass Index (BMI), KG/M

Underweight

<18

Normal range

18.5 – 24

Overweight

25 - 29

Obese

>30

Obese class one

30 – 34

Obese class two

35-39

Obese class three

>40

 Hypertension

A chronic medical disease known as hypertension (HTN) or high blood pressure (BP) is characterized by excessive blood pressure in the arteries. It can be categorized as secondary or primary (essential)(28) . Primary hypertension, or high blood pressure for which no known medical reason can be identified, accounts for 90 to 95 percent of cases. The other 5–10% of instances, referred to as secondary hypertension, are brought on by other illnesses that impact the heart, arteries, kidneys, or endocrine system(29). HTN is a major cause of chronic kidney failure and a risk factor for heart attacks, strokes, heart failure, and arterial aneurysms. A moderate increase in arterial blood pressure reduces life expectancy. Medication, food, and lifestyle modifications can all help regulate blood pressure and lower the risk of related health issues(30).

Classification

In general, diastolic and systolic blood pressures are employed to classify hypertension. Heartbeat-related The term systolic blood pressure refers to blood pressure.  A heart's diastolic pressure is measured in between heartbeats. A person is categorized if their systolic or diastolic blood pressure values above the usual allowed norms for their age, they are classified as pre-HTN or HTN. HTN stage I, HTN stage II, and isolated systolic hypertension are some of the several subclassifications. of hypertensionsystolic or diastolic blood pressure readings that are greater above the commonly recognized normal levels for their age, as pre-HTN or HTN. Among the other subclassifications are isolated systolic hypertension, HTN stage I, and HTN stage II. People older than A person is considered to have hypertension if their blood pressure consistently remains at least 140 mmHg systolic or 90 mmHg diastolic. For those the diabetes or renal illness who also have blood pressure readings more than 130/80 mmHg, additional medication is required. Additionally, HTN is categorized as medication resistant. are unable to lower blood pressure to normal. Exercise hypertension is the term used to describe excessively elevated blood pressure during physical activity. Systolic measurements when exercising fall within the usual range of 200 to 230 mmHg. Exercise hypertension may be a sign that a person is susceptible to resting-state hypertension(31).

 

Table 2. Blood Pressure Ranges

 

Blood Pressure Category

Systolic

(MM/HG)

Diastolic

(MM/HG)

Healthy

Less than 120

Less than 180

Elevated

120-129

<80

Stage 1 Hypertension

130-139

80-89

Stage 2 Hypertension

>140

>90

Hypertension crisis

>180

>120

 

Cholesterol

There are two types of cholesterol

• Low-density lipoprotein (LDL) cholesterol: People frequently refer to this type of cholesterol as "bad." When levels are high, LDL can contribute to blocked arteries.

High-density lipoprotein (HDL) cholesterol: This type of cholesterol is sometimes referred to as "good." LDL cholesterol is reduced in the blood by HDL.

 

 

 

 

Figure 2. Types Of Cholesterol

 

Hyperinsulinemia or insulin resistance combined with dyslipidemia (high triglycerides, low HDL-C) level. Other phenotypes, including altered fibrinolysis, microalbuminuria, small dense low-density lipoprotein (LDL) particles, and indicators of acute phase reactants, have been linked to central obesity. It is not unexpected that the prevalence of multiple sclerosis (MS) and its effect on the chance  of coronary heart disease (CHD) in the community were not readily apparent given the rapidly changing understanding of risk factor clusters(32). Therefore, it is appropriate to assess the incidence of MS and its impact on the risk of CHD in both high and low LDL-cholesterol (LDL-C) populations [11]. The National Cholesterol Education Program's Third Adult Treatment Panel (NCEP ATPIII) regarded T2D as the pinnacle of MetS and MetS as a risk factor for CVD. This panel, which was primarily made up of lipidologists and cardiologists, created a straightforward clinical definition of the MetS that omitted the requirement to determine IR and included fasting hyperglycemia (without an upper limit) as one of its components(32).

Ayurveda
India is referred to as the world's Botanical Garden. There are numerous Indian medicines that are utilized to treat metabolic syndrome(33).
The Doshic dominance of the disease is the focus of the dietary and lifestyle management recommendations; patients with Kaphaja Prameha (Prameha in which Kapha is the predominant Dosha) should eat more catabolic food, while those with Vataja Prameha (Prameha in which Vata is the predominant Dosha) should eat more anabolic food.
(34). For patients with Vataja Prameha, the Charaka Samhita and Sushruta Samhita both suggest anabolic therapies called Santarpana and Brimhana(35). Amalaki and Haridra (turmeric) are regarded in Ayurveda as one of the most effective straightforward herbal remedies for Prameha. They can be consumed as a part of the diet or in powdered form because Amalaki is a seasonal fruit, and Haridra is a spice that is frequently used in the cooking of many different foods. Other spices with antidiabetic qualities include cinnamon, Jeeraka (Cuminum cyminum Linn., cumin), Rasona (Allium sativum Linn., garlic), Shunthi (Zingiber offcinale Rosc., ginger), and Methika (Trigonella foenum-graecum Linn., fenugreek).(36). People with type 2 diabetes who consume cinnamon have lower levels of triglycerides, low-density lipoprotein (LDL), and serum glucose.33, Cumin lowers plasma cholesterol, triglycerides, glycosylated hemoglobin, and blood glucose in rats with diabetes caused by alloxan(37).

General Description

  1. Cinnamon

One frequent herb that is used in both food and industry is cinnamon. Its oil may be used as an antiseptic, antitussive, antibacterial, antioxidant, or an analgesic in traditional medicine(38). Traditional medicine and new scientific research support the use of the active ingredients in cinnamon, such as cinnamon aldehyde. There are several therapeutic applications for eugenol, cinnamonate, and cinnamic acid aqueous and alcoholic extracts. Numerous symptoms of Metabolic Syndrome, including high blood pressure, dyslipidemia, obesity, and elevated blood glucose, can be alleviated by cinnamon extracts. Cinnamon has been demonstrated in studies to be a cardiovascular preventative agent and may help lessen the challenges associated with Metabolic Syndrome because of its anti-diabetic, antioxidant, anti-inflammatory, and lipid profile-beneficial qualities. Frequently called the "Ceylon cinnamon tree" or the "true cinnamon tree" Cinnamomum verum (previously C. zeylanicum) is a medicinal plant that is a member of the Lauraceae family. The little tropical tree C. verum is native to East and Middle Asia, including India and Sri Lanka(39).

Phamacognostical Characteristics

The leathery, typically opposite, lanceolate to ovate leaves of the C. verum tree, which reaches a height of about 10 m, are lanceolate to ovate and have sharp points. The tubular, six-lobed, pale-yellow flowers are borne in panicles as long as the leaves. When ripe, the little fruit, which is 1 to 1.5 cm long, becomes black(40).

  1. Zingiber officinale

Many dishes and beverages employ ginger, or Zingiber officinale, as a flavoring. Since ancient times, people all over the world have utilized it as a natural cure to treat a variety of illnesses(41). According to phytochemical investigation, Zingiber officinale contains non-volatile substances such zingiberone, zingiberole, and zingiberene as well as phenolic compounds like gingerols, shogaols, and paradols. In addition to decreasing blood pressure and blood sugar, ginger has hypolipidemic, hypoglycemic, immunomodulatory, antioxidant, antiemetic, and anti-inflammatory properties. Ginger is a hypoglycemic food additive that has shown promise in treating type 2 diabetes in humans, according to numerous research conducted on both humans and animals. In order to maintain blood glucose homeostasis, ginger works by regulating insulin secretion and encouraging glucose clearances in peripheral tissues that are insulin responsive(42). The well-known spice ginger is made from the rhizome plant Zingiber officinale Rosco (Zingiberaceae) and has been used extensively in cooking. It has a variety of phytochemicals and physiologically active substances, including shogaols and gingerols. In addition to its many traditional medicinal use, ginger and its primary bioactive ingredients have been shown to reduce obesity in cell lines and rodent animal models(43). For instance, administering ginger extract helps stop obesity resulting from a diet heavy in fat. In this study, we examined how ginger affected energy metabolites that are involved in the TCA cycle and glycolysis, as well as how ginger administration affected the levels of several important genes and proteins(44). Lastly, we suggested the chemical mechanism behind the browning action caused by ginger. The current study may provide new light on ginger's ability to prevent obesity(45)

  1. Aloe vera Gel

Participants in the trial were type-2 diabetics with a diagnosis of hyperlipidemia and/or hypercholesterolemia. The randomized double-blind placebo-controlled clinical trial involved participants aged 40–60 who were receiving oral hypoglycemic drugs (metformin and glyburide) rather than anti-hyperlipidemic drugs [46]. In order to assess the antihyperlipidemic potential and safety factors, the test group (n = 33) received 300 mg of aloe vera capsules every 12 hours for two months. As a placebo, toast powder was provided to the other group. At the conclusion of the study period, the aloe vera therapy significantly reduced fasting blood glucose, HbA1c, total cholesterol, and LDL levels in comparison to the placebo. Throughout the course of the study, no negative effects of the therapy were noted. The leaf gel is suggested by the authors as an antihyperglycemic and antihyperlipidemic treatment for diabetic patients(46).

  1.  Ashwagandha. (W. Somnifera)

Ashwagandha, or W. somnifera, is a member of the Solanaceae family. W. somnifera is categorized as a "Rasayana" in Ayurveda because of its anti-aging and health-promoting qualities. In many parts of the world, this significant medicinal herb is also utilized to treat a variety of illnesses(47). With its unique horse-like scent, the root has anti-microbial, anti-inflammatory, neuroprotective, antioxidant, and aphrodisiac qualities. Due to its reputation for promoting lifespan and rejuvenation, ashwagandha is widely used in both traditional and alternative medicine. The most well-known form of ashwagandha is fresh ashwagandha, or Nagori ashwagandha, and its roots and leaves are primarily utilized for a variety of therapeutic applications. The impact of several W. somnifera components and active substances on the risk variables linked to MetS is examined in this review(48). In Ayurveda, traditional plants like W. somnifera (ashwagandha) have long been used for therapeutic purposes. Recent research has shown that ashwagandha has a variety of possible medicinal benefits, particularly when it comes to its active ingredients, withanolides A and D. Through a number of mechanisms, including blocking HMG-CoA, increasing glucose absorption, and boosting insulin sensitivity, these substances show promise in preventing MetS(49).

  1. Carica Papaya

The popular papaya, Carica papaya, is one of the plants having health benefits. This fruit has high levels contains bioactive substances, vitamins, and lipids are  prevent hypercholesterolemia, protect in opposition to oxidative stress and thrombogenesis, both lower inflammatory markers or anti-platelet aggregation—all of which can be brought on by obesity(50). Around the world, carica papaya is consumed unprocessed or transformed into pulp, jam, and confections. Other plant components, including as the The addition of leaves and seeds to various goods, such as flours and teas, to increase their nutritional content. Apart from minerals like potassium and magnesium and vitamin B complex like folate and Three important vitamin sources with potential antioxidant activity are present in the pulp composition, including pantothenic acid. A, C, and E. Food fibers are also present(51). Excessive body fat accumulation is the hallmark of obesity, which incorporates a number of ethological elements, including genetic, metabolic, social, behavioral, environmental, cultural, and psychological ones. Obesity can pose a major health risk. Excessive visceral fat accumulation is known to play a significant role in the emergence of metabolic disorders, such as arterial hypertension, dyslipidemia, and insulin resistance, as well as changes that support the onset of type 2 diabetes and cardiovascular diseases. Therefore, the collection of these risk factors, or a group of metabolic diseases linked to obesity, such as insulin resistance, atherogenic dyslipidemia, and hypertension, which might result in cardiovascular diseases, can be referred to as the metabolic syndrome(50).

6. Elettaria cardamomum (Cardamom)

Elettaria cardamomum, commonly referred to as cardamon, is a member of the Zingiberaceae family. It can be found in Bangladesh, Pakistan, Burma, the Indian subcontinent, and tropical and subtropical Asia. In numerous studies, cardamom and its active components have been shown to alter blood total cholesterol (TC), TG, LDL, and HDL. A thin, papery black shell envelops the triangular pod in cross-section of the tiny cardamom seeds(52).

7. Azadirachta indica (Neem)

An evergreen tree native to Southeast Asia, neem (Azadirachta indica) is found throughout the Indian subcontinent. The maximum height that this tree may reach is 15 to 20 meters, and occasionally up to 35 to 40 meters. The Persian language is the source of the word "A. indica." The dirakht means "tree," the Azad means "free," and "I" stands for "Indian origin(53)." The common names for neem include Nimbay, Veppai, Ariyaveppu, and Vepa in India. Blood pressure, hypertension, hypotension, antihypertensive, dyslipidemia, hyperlipidemia, high triglycerides, high cholesterol, and hypercholesterolemia Hyperglycemia, insulin, hypoglycemia ,antihyperglycemic, antidiabetic, blood glucose, neem, atherogenic, atherosclerosis, excessive weight, hunger, anti-obesity, diabetes, weight reduction, hypertriglyceridemia, and neem are all utilized as herbs(54).

8. Camellia sinensis. (Green tea)

Even though Camellia sinensis belongs to the family Theaceae., won't cause you to lose weight quickly, its leaves will increase your metabolic rate by 4% not including raising your heart rate since they promote fat oxidation or thermogenesis. According to a human study on green tea extract, males Those who consumed the epigallocatechin-3-gallate (EGCG) extract burnt more calories. each day than those in the placebo group. This suggests that the extract thermogenic properties could be crucial in reducing obesity(55).

9.Berberine

An alkaloid that is now attracting a lot of attention is berberine, which has potent pharmacological properties(56). Though it has long been utilized as a plant extract in traditional medicine, recent research techniques have shown that berberine is a promising treatment for modern illnesses(57). Recent research has validated the importance of its anticancer properties and its efficacy in treating cardiovascular, metabolic, or neurological conditions(58). The substance has undergone numerous clinical assessments in individuals with metabolic syndrome(56).

 

 

 

 

Figure 3. Used of berberine

 

Risk Factors of Metabolic Syndrome

Following factor that are chances to increase metabolic disease.

  1. Age

Less than 10% of people in their 20s and 40% of adults in their 60s have MetS, a condition whose risk rises with age. Nonetheless, some studies indicate that roughly one out of every eight school-age children have three or more MetS components. Decades later, another study found a link between childhood MetS and adult cardiovascular disease (59).

2. Race

Less than 10% of persons in their 20s and 40% of adults in their 60s have MetS, a condition whose risk rises with age. Nonetheless, some studies indicate that roughly one out of every eight school-age children have three or more MetS components (60).

3. Obesity

The risk of MetS is increased if one's body mass index (BMI), which is a measurement of the proportion of body fat based on height and weight, is more than 25. Compared to excess fat on other body areas, such the hips, excess fat in the abdomen is a higher risk factor for heart disease. Consequently, abdominal obesity—that is, having an apple-shaped body rather than a pear-shaped one—also occurs(61).

4. History of Diabetes

The presence of a family history of type 2 diabetes or gestational diabetes during pregnancy increases the risk of developing Mets (62).

5. Other Disease

The risk of MetS is further increased by a diagnosis of polycystic ovarian syndrome, cardiovascular illness, gallstones, fatty liver, or breathing issues during sleep. These metabolic disorders impact a woman's hormones and reproductive system (38).

 

 

 

 

Figure 4. Risk Factor of Metabolic Syndromes

 

 

 

 

Lifestyle Caused Metabolic Syndrome

  1. Diet

Among the most effective therapies to make everything better MetS problems is weight loss.  An imbalance in energy intake and expenditure is the main cause of overweight and obesity, which are parts of the metabolic syndrome. About 60% of people in India suffer from an unhealthy diet, which accounts for 20% of all fatalities in the nation. One way to manage MetS is to make the following dietary adjustments.(63).                                                                                                                                 

  1. Lack of physical exercise

Despite the well-established and empirically validated health advantages of physical activity, about 70% of Polish males and more than 60% of Indian women do not routinely engage in physical activity(64). reducing triglyceride levels, raising HDL-C levels, and enhancing glycaemic control because of enhance tissue sensitivity to insulin, and lowering blood pressure are all significant advantages of physical activity as seen by the MetS [66]. According to the most recent guidelines from the European Society of Cardiology, an adult's weekly physical activity should be at least as high as possible to lower all-cause mortality, CV mortality, and morbidity.

  1. Alcohol consumption

India's average annual alcohol intake is 10.6 liters per person. Numerous population studies demonstrate that "none is the lowest degree of alcohol safety." and drinking alcohol raises the risk of cardiovascular disease, overweight, obesity, depression, and suicide in addition to cancer. Alcohol's high calorie content and lack of nutrients cause it to have a negative impact on body weight. When it comes to MetS, alcohol also raises levels of uric acid, cholesterol, and blood pressure (65).

  1. Sleep and Circadian Rhythm

Getting enough sleep, both in terms of quantity and quality, is essential to sustaining an ideal body weight. A person should aim for six to eight hours of sleep per night, or 1/3 to 1/4 of a day since there is a chance that this will result in weight gain. and various symptoms of Mets. with consistent wake-up or sleep schedules exposure to blue light from electronic devices that emit light, such as tablets and smartphones, Use the bed just for sleeping and having sex, and make the bedroom as dark as you can.(66) .

 

Specific name

Traditional name

Family

Administration

Part used

Reference

Cinnamon

Dalchini

Lauraceae

Oral

Bark

(67)

Zingiber officinale

singabera

Zingiberaceae

Oral

Root

[41]

Aloe vera

Ghrit Kumari

Liliaceae

Oral

Leaves

[46]

Ashwagandha (W. somnifera)

Indian ginseng

Solanaceae

Oral

Root

[48]

Carica papaya

Papaya

Caricaceae

Oral

Fruit

[51]

Cardamomum

Elaichi

Zingiberaceae

Oral

Seed

[53]

Azadirachta indica

Neem

Mahogany

Oral

Leaf

[54]

Camellia sinensis

Green Tea

Theaceae

Oral

Leaves

[53]

Berberine

Chitra

Berberidaceae

Oral

Root

[56]

Bitter melon

Momordica charantia

Cucurbitaceae

Oral

Fruit

(68)

Fenugreek

Methi

Fabaceae

Oral

Seed

(69)

Moringa

Sainjna

Moringaceae

Oral

Leaves

(70)

Turmeric

Haldi

Zingiberaceae

Oral

Rhizome

(71)

Russian tarragon

Dragon Herb

Asteraceae

Oral

Leaves

(72)

Hibiscus

Gudhal

Malvaceae

Oral

Flower

(73)

Olive Leaf

Zaitoon

Oleaceae

Oral

Leaves

(74)

Gymnema Sylvestre

Gurmar

Apocynaceae

Oral

Leaves

(67)

Yerba Mate

Mate

Aquifoliaceae

Oral

Leaves

(75)

Dandelion Root

detox herb

Asteraceae

Oral

Leaves

(76)

Holy Basil

Tulsi

Lamiaceae

Oral

Leaves

(77)

Amalaki

Indian gooseberry

Lamiaceae

Oral

Fruit

(78)

Motherwort

herbalism

Lamiaceae

Oral

Leaves

(79)

Rosemary

Gulmehendi

Lamiaceae

Oral

Leaves\Steam

(80)

Nigella sativa

Black seed

Nigella sativa

Oral

Seed

(81)

Thymus vulgaris

Thyme

Lamiaceae

Oral

Leaves

(82)

Medicago sativa

Alfalfa

Fabaceae

Oral

Leaves

(83)

Vaccinium spp

Blueberry Leaves

Ericaceae

Oral

Leaves\Berries

(84)

Lagerstroemia speciosa

Banaba Leaf

Lythraceae

Oral

Leaves

(85)

Rosmarinus officinalis

Rosemary

Lamiaceae

Oral

Leaves

(86)

Nigella sativa

Black Seed

Ranunculaceae

Oral

Seed

(81)

Phaseolus vulgaris

White Kidney Bean

Fabaceae

Oral

Seed

(87)

Commiphora Mukul

Guggul

Burseraceae

Oral

Resin

(88)

Cynara scolymus

Artichoke Leaf

Asteraceae

Oral

Leaves

(89)

Emblica officinalis

Amla

Phyllanthaceae

Oral

Fruit

(90)

Pterocarpus marsupium

Vijaysar

Fabaceae

Oral

Heartwood

(91)

Acacia arabica

Gum Arabic

Fabaceae

Oral

Gum

(92)

 

Contraindications of herbal alternatives

Because of their efficacy, lack of adverse effects, wide spectrum of action, and affordability, herbal medications are frequently given. The quality and consistency of the active ingredients in non-trial medications, however, are typically not assessed; they frequently contain impurities and may exhibit batch-to-batch fluctuations(93). It's frequently unclear how exactly they work to lower blood sugar. Furthermore, due to a lack of standardization, these herbs could not be effective for everyone, and their total effects might differ from person to person. Pre-clinical trials for poly-herbal formulations are being developed because different patients may experience different side effects and because a combination of these herbs may be needed to produce the desired outcome (94). Among  many drawbacks or restrictions of herbal medicines are the following: a) the fact that they are self-prescribed, quality assurance is not guaranteed, and they may interact with other medications; b) herbal drug contraindications and related unusual beliefs; c) the presence of potent, pharmacologically active compounds that require evaluation for drug-drug interactions; d) the fact that they typically cause hepatic and renal problems if taken in excess; e) the lack of pharmacodynamics and pharmacokinetics data and the slow rate of clearance from the body; e) the difficulty of identifying the causative agent associated with the adverse reactions encountered because they frequently contain multiple ingredients, lack of uniformity in the formulation of herbal drugs, such as delivery systems for specific targets, which is typically not validated; and g) the Mode of Action of elements of herbal plants is not sufficiently known to support therapeutic utility(95). Changes or issues that arise when treatment produces unintended side effects are referred to as complications. Depending on the individual, they might range from minor to severe. Chemical or synthetic medications typically result in difficulties or negative effects. Herbal plants typically don't cause any negative side effects when evaluated over a longer time span in human history. However, because non-standardized herbal formulations are not standardized, pharmacological and toxicological examination may result in certain undesirable effects(96). The presence of impurities or adulterants, not the active ingredient itself, is what causes these effects. These contraindications manifest as physical conditions that put certain individuals at risk of harm while utilizing a certain herbal composition, creating an ironic scenario where risk outweighs benefit. Whether self-prescribed or used to treat both acute and chronic diseases, the safety of herbal medications is a serious problem(97). The majority of patients who use herbal remedies, however, are unaware of the possible negative consequences of these preparations. Given that pregnant and lactating women are more vulnerable to herbal toxicities or adverse responses, it is important to determine that these populations should exercise extra caution. Certain chemicals found in herbs have the ability to penetrate the placenta and are unmistakably connected to birth abnormalities or other issues in babies(98). Pre-clinical investigations should thus additionally assess the safety against teratogenic effects. Compared to adults, children and babies are far more susceptible to the negative effects of any medications, even herbal ones. Herbs may cause increased toxic or unpleasant effects in older people with diabetes, cardiovascular issues, and other chronic illnesses. Standardization before commercial usage is the key to addressing these related constraints of herbal medications(99).

CONCLUSION:

Medicinal herbs are increasingly being recognized as a beneficial adjunctive treatment approach for the management of metabolic syndrome.  As a result of the limitations of conventional therapies, ashwagandha, cinnamon, and ginger are just a few natural products that hold promise for the treatment of obesity, hypertension, and insulin resistance.  To improve overall metabolic well-being, Ayurvedic approaches provide tailored herbal and dietary treatments in conjunction with lifestyle modifications such as diet and exercise. By integrating these natural remedies with modern medicine, long-term care can be enhanced and dependence on pharmaceutical therapies can be reduced.

List of Abbreviations:

Mets – Metabolic syndrome

LDL- Low density lipoprotein

HDL- High density lipoprotein

ASCVD- Atherosclerotic cardiovascular disease

WHO- World Health Organization

IDF- International Diabetes Federation

DM- Diabetes Meletus

T2DM- Type 2 diabetes Meletus

GDM- Gastrointestinal diabetes Meletus

HTN- Hypertension

BP- Blood pressure

CHD- coronary heart disease

MS- Multiple sclerosis

CVD- cardiovascular disease

Hb- Hemoglobin

NCEPATP 3- National cholesterol education program third adult treatment Pannel

TC- Total cholesterol

EGCG- Epigallocetachin-3-gallate

BMI- Body mass index

HMG-COA- 3-Hydroxy-3-methylglutaryl coenzyme A

MOA- Mode of Action

REFERENCES

        1. Heindel JJ, Blumberg B, Cave M, Machtinger R, Mantovani A, Mendez MA, et al. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol. 2017;68:3–33.
        2. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol. 2002;156(11):1070–7.
        3. Ko MM, Jang S, Jung J. Herbal medicines for metabolic diseases with blood stasis A protocol for a systematic review and meta-analysis. Med (United States). 2019;98(8):18–20.
        4. Abdulghani MF, Al-Fayyadh S. Natural products for managing metabolic syndrome: a scoping review. Front Pharmacol. 2024;15(April):1–19.
        5. Abdulghani MF, Al-Fayyadh S. Natural products for managing metabolic syndrome: a scoping review. Front Pharmacol. 2024;15:1366946.
        6. Mokoena K. Lifestyle practices associated with anthropometric status among students at the University of Venda. 2021.
        7. Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation. 2003;108(13):1541–5.
        8. Bays H, Abate N, Chandalia M. Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia. Future Cardiol. 2005;1(1):39–59.
        9. Gurib-Fakim A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol Aspects Med. 2006;27(1):1–93.
        10. Mukherjee PK, Wahile A. Integrated approaches towards drug development from Ayurveda and other Indian system of medicines. J Ethnopharmacol. 2006;103(1):25–35.
        11. Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TPA. Recent Advances in Indian Herbal Drug Research Guest Editor?: Thomas Paul Asir Devasagayam. 2007;(May):163–73.
        12. Akkol EK, Aschner M. An overview on metabolic disorders and current therapy. Role Phytonutrients Metab Disord. 2022;3–33.
        13. Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10(1):1–11.
        14. Singh U. Prevalence of diabetes and other health related problems across India and worldwide: An overview. J Appl Nat Sci. 2016;8(1):500–5.
        15. Semple RK, Savage DB, Cochran EK, Gorden P, O’Rahilly S. Genetic syndromes of severe insulin resistance. Endocr Rev. 2011;32(4):498–514.
        16. Misra A, Khurana L. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Metab Syndr Relat Disord. 2009;7(6):497–514.
        17. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.
        18. Guzman-Vilca WC, Carrillo-Larco RM. Number of people with type 2 diabetes mellitus in 2035 and 2050: A modelling study in 188 countries. Curr Diabetes Rev. 2025;21(1):E120124225603.
        19. Venkatakrishnan K, Chiu HF, Wang CK. Popular functional foods and herbs for the management of type-2-diabetes mellitus: A comprehensive review with special reference to clinical trials and its proposed mechanism. J Funct Foods [Internet]. 2019;57(February):425–38. Available from: https://doi.org/10.1016/j.jff.2019.04.039
        20. Serbis A, Giapros V, Kotanidou EP, Galli-Tsinopoulou A, Siomou E. Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents. World J Diabetes. 2021;12(4):344.
        21. Jeong EW, Dhungana SK, Yang YS, Baek Y, Seo JH, Kang BK, et al. Black and Yellow Soybean Consumption Prevents High-Fat Diet-Induced Obesity by Regulating Lipid Metabolism in C57BL/6 Mice. Evidence-based Complement Altern Med. 2023;2023.
        22. Shekar M, Popkin B. Obesity: health and economic consequences of an impending global challenge. World Bank Publications; 2020.
        23. Lehnert T, Sonntag D, Konnopka A, Riedel-Heller S, König HH. Economic costs of overweight and obesity. Best Pract \& Res Clin Endocrinol \& Metab. 2013;27(2):105–15.
        24. Rahman MM, Islam MR, Shohag S, Hossain ME, Rahaman MS, Islam F, et al. The Multifunctional Role of Herbal Products in the Management of Diabetes and Obesity: A Comprehensive Review. Molecules. 2022;27(5).
        25. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam \& Horm. 2006;74:443–77.
        26. Gerich J, Cryer P, Rizza R. Hormonal mechanisms in acute glucose counterregulation: the relative roles of glucagon, epinephrine, norepinephrine, growth hormone, and cortisol. Metabolism. 1980;29(11):1164–75.
        27. Tabassum N, Ahmad F. Role of natural herbs in the treatment of hypertension. Pharmacogn Rev. 2011;5(9):30–40.
        28. Staessen JA, Wang J, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet. 2003;361(9369):1629–41.
        29. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. Jama. 2002;288(15):1882–8.
        30. Ghaderian SB, Beladi-Mousavi SS. The role of diabetes mellitus and hypertension in chronic kidney disease. J Ren Inj Prev. 2014;3(4):109.
        31. Onat A, Ceyhan K, Ba?ar Ö, Erer B, Toprak S, Sansoy V. Metabolic syndrome: Major impact on coronary risk in a population with low cholesterol levels - A prospective and cross-sectional evaluation. Atherosclerosis. 2002;165(2):285–92.
        32. Osadchuk MA, Vasilieva IN, Kozlov V V., Mitrokhina OI. Metabolic syndrome as a risk factor for oncogenesis. Profil Meditsina. 2023;26(1):70–9.
        33. Grover JK, Yadav S, Vats V. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol. 2002;81(1):81–100.
        34. Ahlawat V, Ohlan Pk. A Comprehensive Review of The Benefits of Panchakarma In Lifestyle Disorders. 2024;
        35. Rajapurohit KA. A Study on the Etiopathogenesis of Apathya Nimittja Madhumeha WSR to Niddm Type 2 \& its Samprapti Vighatana by Nishatriphaladi Yoga. Rajiv Gandhi University of Health Sciences (India); 2014.
        36. Kurlgeri MR. The Study of Naradi Vaidya Prakarana in Lokopakara and its Contribution to Ayurveda. Rajiv Gandhi University of Health Sciences (India); 2014.
        37. Sharma H, Chandola HM. Prameha in ayurveda: Correlation with obesity, metabolic syndrome, and diabetes mellitus. part 2-management of Prameha. J Altern Complement Med. 2011;17(7):589–99.
        38. Arozal W, Louisa M, Soetikno V. Selected indonesian medicinal plants for the management of metabolic syndrome: Molecular basis and recent studies. Front Cardiovasc Med. 2020;7(May).
        39. Mollazadeh H, Hosseinzadeh H. Cinnamon effects on metabolic syndrome: A review based on its mechanisms. Iran J Basic Med Sci. 2016;19(12):1258–70.
        40. Plant biodiversity. Environ Sci Eng. 2015;145:39–243.
        41. Shahrajabian MH, Sun W, Cheng Q. Clinical aspects and health benefits of ginger (Zingiber officinale) in both traditional Chinese medicine and modern industry. Acta Agric Scand Sect b—Soil \& Plant Sci. 2019;69(6):546–56.
        42. Yedjou CG, Grigsby J, Mbemi A, Nelson D, Mildort B, Latinwo L, et al. The Management of Diabetes Mellitus Using Medicinal Plants and Vitamins. Int J Mol Sci. 2023;24(10).
        43. Seo SH, Fang F, Kang I. Ginger (Zingiber officinale) attenuates obesity and adipose tissue remodeling in high-fat diet-fed C57BL/6 mice. Int J Environ Res Public Health. 2021;18(2):631.
        44. Fu M, Liu Y, Cheng H, Xu K, Wang G. Coptis chinensis and dried ginger herb combination inhibits gastric tumor growth by interfering with glucose metabolism via LDHA and SLC2A1. J Ethnopharmacol. 2022;284:114771.
        45. Lee YG, Lee SR, Baek HJ, Kwon JE, Baek NI, Kang TH, et al. The Effects of Body Fat Reduction through the Metabolic Control of Steam-Processed Ginger Extract in High-Fat-Diet-Fed Mice. Int J Mol Sci. 2024;25(5):2982.
        46. Naveen YP, Urooj A, Byrappa K. A review on medicinal plants evaluated for anti-diabetic potential in clinical trials: Present status and future perspective. J Herb Med [Internet]. 2021;28(August 2020):100436. Available from: https://doi.org/10.1016/j.hermed.2021.100436
        47. Kaul S, Wadhwa R. Ashwagandha for Quality of Life: Scientific Evidence. CRC Press; 2024.
        48. Meher SK, Das B, Panda P, Bhuyan GC, Rao MM. Uses of Withania somnifera (Linn) Dunal (Ashwagandha) in Ayurveda and its pharmacological evidences. Res J Pharmacol Pharmacodyn. 2016;8(1):23–9.
        49. Rakha A, Ramzan Z, Umar N, Rasheed H, Fatima A, Ahmed Z, et al. The Role of Ashwagandha in Metabolic Syndrome: A Review of Traditional Knowledge and Recent Research Findings. J Biol Regul Homeost Agents [Internet]. 2023;(October):5091–103. Available from: https://www.biolifesas.org/EN/10.23812/j.biol.regul.homeost.agents.20233710.494
        50. Santana LF, Inada AC, Santo BLS do E, Filiú WFO, Pott A, Alves FM, et al. Nutraceutical potential of carica papaya in metabolic syndrome. Nutrients. 2019;11(7).
        51. Jaiswal AK. Nutritional composition and antioxidant properties of fruits and vegetables. Academic Press; 2020.
        52. Yahyazadeh R, Rahbardar MG, Razavi BM, Karimi G, Hosseinzadeh H. The effect of elettaria cardamomum (cardamom) on the metabolic syndrome: narrative review. Iran J Basic Med Sci. 2021;24(11):1462–9.
        53. Chowdhary A, Singh V. Geographical distribution, ethnobotany and indigenous uses of neem. Neem, a Treatise, IK Int. 2009;20.
        54. Yarmohammadi F, Mehri S, Najafi N, Amoli SS, Hosseinzadeh H. The protective effect of Azadirachta indica (neem) against metabolic syndrome: A review. Iran J Basic Med Sci. 2021;24(4):280–92.
        55. Verma RK, Paraidathathu T. Herbal medicines used in the traditional Indian medicinal system as a therapeutic treatment option for overweight and obesity management: A review. Int J Pharm Pharm Sci. 2014;6(SUPPL. 2):40–7.
        56. Och A, Och M, Nowak R, Podgórska D, Podgórski R. Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease. Molecules. 2022;27(4):1–32.
        57. Kong Y, Li L, Zhao LG, Yu P, Li DD. A patent review of berberine and its derivatives with various pharmacological activities (2016--2020). Expert Opin Ther Pat. 2022;32(2):211–23.
        58. Benavente-Garcia O, Castillo J. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem. 2008;56(15):6185–205.
        59. Beltrán-Sánchez H, Harhay MO, Harhay MM, McElligott S. Prevalence and trends of metabolic syndrome in the adult US population, 1999--2010. J Am Coll Cardiol. 2013;62(8):697–703.
        60. Daniels SR, Pratt CA, Hayman LL. Reduction of risk for cardiovascular disease in children and adolescents. Circulation. 2011;124(15):1673–86.
        61. Liu P, Ma F, Lou H, Liu Y. The utility of fat mass index vs. body mass index and percentage of body fat in the screening of metabolic syndrome. BMC Public Health. 2013;13:1–8.
        62. Gunderson EP, Chiang V, Pletcher MJ, Jacobs Jr DR, Quesenberry Jr CP, Sidney S, et al. History of gestational diabetes mellitus and future risk of atherosclerosis in mid-life: the coronary artery risk development in young adults study. J Am Heart Assoc. 2014;3(2):e000490.
        63. la Iglesia R, Loria-Kohen V, Zulet MA, Martinez JA, Reglero G, de Molina A. Dietary strategies implicated in the prevention and treatment of metabolic syndrome. Int J Mol Sci. 2016;17(11):1877.
        64. Stodolska M, Shinew KJ, Floyd MF, Walker G. Race, ethnicity, and leisure: Perspectives on research, theory, and practice. 2013;
        65. Lubawy M, Formanowicz D. High-fructose diet--induced hyperuricemia accompanying metabolic syndrome--mechanisms and dietary therapy proposals. Int J Environ Res Public Health. 2023;20(4):3596.
        66. Dobrowolski P, Prejbisz A, Kurylowicz A, Baska A, Burchardt P, Chlebus K, et al. Metabolic syndrome a new definition and management guidelines. Arch Med Sci. 2022;18(5):1133–56.
        67. Thakur S, Walia B, Chaudhary G. Dalchini (cinnamomum zeylanicum): a versatile spice with significant therapeutic potential: Cinnamomum Zeylanicum. Int J Pharm Drug Anal. 2021;9(2):126–36.
        68. Basch E, Gabardi S, Ulbricht C. Bitter melon (Momordica charantia): a review of efficacy and safety. Am J Heal Pharm. 2003;60(4):356–9.
        69. Bagchi D, Swaroop A, Maheshwari A, Verma N, Tiwari K, Bagchi M, et al. A novel protodioscin-enriched fenugreek seed extract (Trigonella foenum-graecum, family Fabaceae) improves free testosterone level and sperm profile in healthy volunteers. Funct Foods Heal Dis. 2017;7(4):235–45.
        70. Mishra G, Singh P, Verma R, Kumar S, Srivastav S, Jha KK, et al. Traditional uses, phytochemistry and pharmacological properties of Moringa oleifera plant: An overview. Der Pharm Lett. 2011;3(2):141–64.
        71. Rathaur P, Raja W, Ramteke PW, John SA. Turmeric: The golden spice of life. Int J Pharm Sci Res. 2012;3(7):1987.
        72. Shutes J. Learn about Tarragon Essential Oil--Artemisia dracunculus.
        73. Upadhyay RK. Nutritional, therapeutic, and pharmaceutical potential of Hibiscus species. Int J Green Pharm. 2023;17(04).
        74. Rashid K, Hashimi M, Saleem S. Zaitoon/Olive (Olea europaea) as mentioned in The Holy Qur’an and Ahadith and its Ethno medicinal Importance.
        75. Ferreira Cuelho CH, de França Bonilha I, do Canto G, Palermo Manfron M. Recent advances in the bioactive properties of yerba mate. Rev Cuba Farm. 2015;49(2):375–83.
        76. Bjørklund G, Cruz-Martins N, Goh BH, Mykhailenko O, Lysiuk R, Shanaida M, et al. Medicinal Plant-derived Phytochemicals in Detoxification. Curr Pharm Des. 2024;30(13):988–1015.
        77. Kaur S, Sabharwal S, Anand N, Singh S, Baghel DS, Mittal A. An overview of Tulsi (Holy basil). Eur J Mol \& Clin Med. 2020;7(7):2833–9.
        78. Krupanidhi AM, Dabadi P, Sameera HR, Anusha MM, Deepika B V, Srinivas G, et al. Anti-Oxidant Activities Of Considerable Medicinal Plants: A Review Article. 2022;
        79. Feigel ML, Kennard A, Lannaman K. Herbalism for modern obstetrics. Clin Obstet Gynecol. 2021;64(3):611–34.
        80. Thakur M, Chandel M, Sharma A, Rani A, Sharma A, Kumar N. Indian Journal of Advances in Chemical Science. Indian J Adv Chem Sci. 2022;10(2):85–99.
        81. Gali-Muhtasib H, El-Najjar N, Schneider-Stock R. The medicinal potential of black seed (Nigella sativa) and its components. Adv Phytomedicine. 2006;2:133–53.
        82. Basch E, Ulbricht C, Hammerness P, Bevins A, Sollars D. Thyme (Thymus vulgaris L.), thymol. J Herb Pharmacother. 2004;4(1):49–67.
        83. Samac DA, Austin-Phillips S. Alfalfa (Medicago sativa L.). Agrobacterium Protoc. 2006;301–12.
        84. Vance AJ, Jones P, Strik BC. Foliar calcium applications do not improve quality or shelf life of strawberry, raspberry, blackberry, or blueberry fruit. HortScience. 2017;52(3):382–7.
        85. Stohs SJ, Miller H, Kaats GR. A review of the efficacy and safety of banaba (Lagerstroemia speciosa L.) and corosolic acid. Phyther Res. 2012;26(3):317–24.
        86. Al-Sereiti MR, Abu-Amer KM, Sena P. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. 1999;
        87. Wang S, Chen L, Yang H, Gu J, Wang J, Ren F. Regular intake of white kidney beans extract (Phaseolus vulgaris L.) induces weight loss compared to placebo in obese human subjects. Food Sci \& Nutr. 2020;8(3):1315–24.
        88. Jasuja ND, Choudhary J, Sharama P, Sharma N, Joshi SC. A review on bioactive compounds and medicinal uses of Commiphora mukul. J Plant Sci. 2012;7(4):113.
        89. Bundy R, Walker AF, Middleton RW, Wallis C, Simpson HCR. Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: a randomized, double blind placebo controlled trial. Phytomedicine. 2008;15(9):668–75.
        90. Bhandari PR, Kamdod MA. Emblica officinalis (Amla): A review of potential therapeutic applications. Int J Green Pharm. 2012;6(4).
        91. Tandel K, Deshpande S V, Soni AK, Choudhary Y. Acute Oral Toxicity Study of Nano Vijaysar (Pterocarpus Marsupium Roxb) Hydro Alcoholic Extract In Sprague Dawley Rats. 2022;
        92. Al-Jubori Y, Ahmed NTB, Albusaidi R, Madden J, Das S, Sirasanagandla SR. The efficacy of gum Arabic in managing diseases: A systematic review of evidence-based clinical trials. Biomolecules. 2023;13(1):138.
        93. Rivera JO, Loya AM, Ceballos R. Use of herbal medicines and implications for conventional drug therapy medical sciences. Altern Integ Med. 2013;2(6):1–6.
        94. Ameh SJ, Obodozie OO, Babalola PC, Gamaniel KS. Medical herbalism and herbal clinical research: a global perspective. Br J Pharm Res Sunday J. 2011;1(4):99.
        95. Wink M. Modes of action of herbal medicines and plant secondary metabolites. Medicines. 2015;2(3):251–86.
        96. Wen H, Jung H, Li X. Drug delivery approaches in addressing clinical pharmacology-related issues: opportunities and challenges. AAPS J. 2015;17:1327–40.
        97. Mukherjee PK. Quality control and evaluation of herbal drugs: Evaluating natural products and traditional medicine. Elsevier; 2019.
        98. Steingraber. Having faith: An ecologist’s journey to motherhood Sandra. Hachette UK; 2012.
        99. Yadav N, Singh Chandel S, Venkatachalam T, Fathima SN. Herbal Medicine Formulation, standardization, and Commercialization challenges and sustainable strategies for improvement. In: Herbal Medicine Phytochemistry: Applications and Trends. Springer; 2024. p. 1769–95.

Reference

 

  1. Heindel JJ, Blumberg B, Cave M, Machtinger R, Mantovani A, Mendez MA, et al. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol. 2017;68:3–33.
  2. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol. 2002;156(11):1070–7.
  3. Ko MM, Jang S, Jung J. Herbal medicines for metabolic diseases with blood stasis A protocol for a systematic review and meta-analysis. Med (United States). 2019;98(8):18–20.
  4. Abdulghani MF, Al-Fayyadh S. Natural products for managing metabolic syndrome: a scoping review. Front Pharmacol. 2024;15(April):1–19.
  5. Abdulghani MF, Al-Fayyadh S. Natural products for managing metabolic syndrome: a scoping review. Front Pharmacol. 2024;15:1366946.
  6. Mokoena K. Lifestyle practices associated with anthropometric status among students at the University of Venda. 2021.
  7. Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation. 2003;108(13):1541–5.
  8. Bays H, Abate N, Chandalia M. Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia. Future Cardiol. 2005;1(1):39–59.
  9. Gurib-Fakim A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol Aspects Med. 2006;27(1):1–93.
  10. Mukherjee PK, Wahile A. Integrated approaches towards drug development from Ayurveda and other Indian system of medicines. J Ethnopharmacol. 2006;103(1):25–35.
  11. Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TPA. Recent Advances in Indian Herbal Drug Research Guest Editor?: Thomas Paul Asir Devasagayam. 2007;(May):163–73.
  12. Akkol EK, Aschner M. An overview on metabolic disorders and current therapy. Role Phytonutrients Metab Disord. 2022;3–33.
  13. Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10(1):1–11.
  14. Singh U. Prevalence of diabetes and other health related problems across India and worldwide: An overview. J Appl Nat Sci. 2016;8(1):500–5.
  15. Semple RK, Savage DB, Cochran EK, Gorden P, O’Rahilly S. Genetic syndromes of severe insulin resistance. Endocr Rev. 2011;32(4):498–514.
  16. Misra A, Khurana L. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Metab Syndr Relat Disord. 2009;7(6):497–514.
  17. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.
  18. Guzman-Vilca WC, Carrillo-Larco RM. Number of people with type 2 diabetes mellitus in 2035 and 2050: A modelling study in 188 countries. Curr Diabetes Rev. 2025;21(1):E120124225603.
  19. Venkatakrishnan K, Chiu HF, Wang CK. Popular functional foods and herbs for the management of type-2-diabetes mellitus: A comprehensive review with special reference to clinical trials and its proposed mechanism. J Funct Foods [Internet]. 2019;57(February):425–38. Available from: https://doi.org/10.1016/j.jff.2019.04.039
  20. Serbis A, Giapros V, Kotanidou EP, Galli-Tsinopoulou A, Siomou E. Diagnosis, treatment and prevention of type 2 diabetes mellitus in children and adolescents. World J Diabetes. 2021;12(4):344.
  21. Jeong EW, Dhungana SK, Yang YS, Baek Y, Seo JH, Kang BK, et al. Black and Yellow Soybean Consumption Prevents High-Fat Diet-Induced Obesity by Regulating Lipid Metabolism in C57BL/6 Mice. Evidence-based Complement Altern Med. 2023;2023.
  22. Shekar M, Popkin B. Obesity: health and economic consequences of an impending global challenge. World Bank Publications; 2020.
  23. Lehnert T, Sonntag D, Konnopka A, Riedel-Heller S, König HH. Economic costs of overweight and obesity. Best Pract \& Res Clin Endocrinol \& Metab. 2013;27(2):105–15.
  24. Rahman MM, Islam MR, Shohag S, Hossain ME, Rahaman MS, Islam F, et al. The Multifunctional Role of Herbal Products in the Management of Diabetes and Obesity: A Comprehensive Review. Molecules. 2022;27(5).
  25. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam \& Horm. 2006;74:443–77.
  26. Gerich J, Cryer P, Rizza R. Hormonal mechanisms in acute glucose counterregulation: the relative roles of glucagon, epinephrine, norepinephrine, growth hormone, and cortisol. Metabolism. 1980;29(11):1164–75.
  27. Tabassum N, Ahmad F. Role of natural herbs in the treatment of hypertension. Pharmacogn Rev. 2011;5(9):30–40.
  28. Staessen JA, Wang J, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet. 2003;361(9369):1629–41.
  29. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. Jama. 2002;288(15):1882–8.
  30. Ghaderian SB, Beladi-Mousavi SS. The role of diabetes mellitus and hypertension in chronic kidney disease. J Ren Inj Prev. 2014;3(4):109.
  31. Onat A, Ceyhan K, Ba?ar Ö, Erer B, Toprak S, Sansoy V. Metabolic syndrome: Major impact on coronary risk in a population with low cholesterol levels - A prospective and cross-sectional evaluation. Atherosclerosis. 2002;165(2):285–92.
  32. Osadchuk MA, Vasilieva IN, Kozlov V V., Mitrokhina OI. Metabolic syndrome as a risk factor for oncogenesis. Profil Meditsina. 2023;26(1):70–9.
  33. Grover JK, Yadav S, Vats V. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol. 2002;81(1):81–100.
  34. Ahlawat V, Ohlan Pk. A Comprehensive Review of The Benefits of Panchakarma In Lifestyle Disorders. 2024;
  35. Rajapurohit KA. A Study on the Etiopathogenesis of Apathya Nimittja Madhumeha WSR to Niddm Type 2 \& its Samprapti Vighatana by Nishatriphaladi Yoga. Rajiv Gandhi University of Health Sciences (India); 2014.
  36. Kurlgeri MR. The Study of Naradi Vaidya Prakarana in Lokopakara and its Contribution to Ayurveda. Rajiv Gandhi University of Health Sciences (India); 2014.
  37. Sharma H, Chandola HM. Prameha in ayurveda: Correlation with obesity, metabolic syndrome, and diabetes mellitus. part 2-management of Prameha. J Altern Complement Med. 2011;17(7):589–99.
  38. Arozal W, Louisa M, Soetikno V. Selected indonesian medicinal plants for the management of metabolic syndrome: Molecular basis and recent studies. Front Cardiovasc Med. 2020;7(May).
  39. Mollazadeh H, Hosseinzadeh H. Cinnamon effects on metabolic syndrome: A review based on its mechanisms. Iran J Basic Med Sci. 2016;19(12):1258–70.
  40. Plant biodiversity. Environ Sci Eng. 2015;145:39–243.
  41. Shahrajabian MH, Sun W, Cheng Q. Clinical aspects and health benefits of ginger (Zingiber officinale) in both traditional Chinese medicine and modern industry. Acta Agric Scand Sect b—Soil \& Plant Sci. 2019;69(6):546–56.
  42. Yedjou CG, Grigsby J, Mbemi A, Nelson D, Mildort B, Latinwo L, et al. The Management of Diabetes Mellitus Using Medicinal Plants and Vitamins. Int J Mol Sci. 2023;24(10).
  43. Seo SH, Fang F, Kang I. Ginger (Zingiber officinale) attenuates obesity and adipose tissue remodeling in high-fat diet-fed C57BL/6 mice. Int J Environ Res Public Health. 2021;18(2):631.
  44. Fu M, Liu Y, Cheng H, Xu K, Wang G. Coptis chinensis and dried ginger herb combination inhibits gastric tumor growth by interfering with glucose metabolism via LDHA and SLC2A1. J Ethnopharmacol. 2022;284:114771.
  45. Lee YG, Lee SR, Baek HJ, Kwon JE, Baek NI, Kang TH, et al. The Effects of Body Fat Reduction through the Metabolic Control of Steam-Processed Ginger Extract in High-Fat-Diet-Fed Mice. Int J Mol Sci. 2024;25(5):2982.
  46. Naveen YP, Urooj A, Byrappa K. A review on medicinal plants evaluated for anti-diabetic potential in clinical trials: Present status and future perspective. J Herb Med [Internet]. 2021;28(August 2020):100436. Available from: https://doi.org/10.1016/j.hermed.2021.100436
  47. Kaul S, Wadhwa R. Ashwagandha for Quality of Life: Scientific Evidence. CRC Press; 2024.
  48. Meher SK, Das B, Panda P, Bhuyan GC, Rao MM. Uses of Withania somnifera (Linn) Dunal (Ashwagandha) in Ayurveda and its pharmacological evidences. Res J Pharmacol Pharmacodyn. 2016;8(1):23–9.
  49. Rakha A, Ramzan Z, Umar N, Rasheed H, Fatima A, Ahmed Z, et al. The Role of Ashwagandha in Metabolic Syndrome: A Review of Traditional Knowledge and Recent Research Findings. J Biol Regul Homeost Agents [Internet]. 2023;(October):5091–103. Available from: https://www.biolifesas.org/EN/10.23812/j.biol.regul.homeost.agents.20233710.494
  50. Santana LF, Inada AC, Santo BLS do E, Filiú WFO, Pott A, Alves FM, et al. Nutraceutical potential of carica papaya in metabolic syndrome. Nutrients. 2019;11(7).
  51. Jaiswal AK. Nutritional composition and antioxidant properties of fruits and vegetables. Academic Press; 2020.
  52. Yahyazadeh R, Rahbardar MG, Razavi BM, Karimi G, Hosseinzadeh H. The effect of elettaria cardamomum (cardamom) on the metabolic syndrome: narrative review. Iran J Basic Med Sci. 2021;24(11):1462–9.
  53. Chowdhary A, Singh V. Geographical distribution, ethnobotany and indigenous uses of neem. Neem, a Treatise, IK Int. 2009;20.
  54. Yarmohammadi F, Mehri S, Najafi N, Amoli SS, Hosseinzadeh H. The protective effect of Azadirachta indica (neem) against metabolic syndrome: A review. Iran J Basic Med Sci. 2021;24(4):280–92.
  55. Verma RK, Paraidathathu T. Herbal medicines used in the traditional Indian medicinal system as a therapeutic treatment option for overweight and obesity management: A review. Int J Pharm Pharm Sci. 2014;6(SUPPL. 2):40–7.
  56. Och A, Och M, Nowak R, Podgórska D, Podgórski R. Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease. Molecules. 2022;27(4):1–32.
  57. Kong Y, Li L, Zhao LG, Yu P, Li DD. A patent review of berberine and its derivatives with various pharmacological activities (2016--2020). Expert Opin Ther Pat. 2022;32(2):211–23.
  58. Benavente-Garcia O, Castillo J. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem. 2008;56(15):6185–205.
  59. Beltrán-Sánchez H, Harhay MO, Harhay MM, McElligott S. Prevalence and trends of metabolic syndrome in the adult US population, 1999--2010. J Am Coll Cardiol. 2013;62(8):697–703.
  60. Daniels SR, Pratt CA, Hayman LL. Reduction of risk for cardiovascular disease in children and adolescents. Circulation. 2011;124(15):1673–86.
  61. Liu P, Ma F, Lou H, Liu Y. The utility of fat mass index vs. body mass index and percentage of body fat in the screening of metabolic syndrome. BMC Public Health. 2013;13:1–8.
  62. Gunderson EP, Chiang V, Pletcher MJ, Jacobs Jr DR, Quesenberry Jr CP, Sidney S, et al. History of gestational diabetes mellitus and future risk of atherosclerosis in mid-life: the coronary artery risk development in young adults study. J Am Heart Assoc. 2014;3(2):e000490.
  63. la Iglesia R, Loria-Kohen V, Zulet MA, Martinez JA, Reglero G, de Molina A. Dietary strategies implicated in the prevention and treatment of metabolic syndrome. Int J Mol Sci. 2016;17(11):1877.
  64. Stodolska M, Shinew KJ, Floyd MF, Walker G. Race, ethnicity, and leisure: Perspectives on research, theory, and practice. 2013;
  65. Lubawy M, Formanowicz D. High-fructose diet--induced hyperuricemia accompanying metabolic syndrome--mechanisms and dietary therapy proposals. Int J Environ Res Public Health. 2023;20(4):3596.
  66. Dobrowolski P, Prejbisz A, Kurylowicz A, Baska A, Burchardt P, Chlebus K, et al. Metabolic syndrome a new definition and management guidelines. Arch Med Sci. 2022;18(5):1133–56.
  67. Thakur S, Walia B, Chaudhary G. Dalchini (cinnamomum zeylanicum): a versatile spice with significant therapeutic potential: Cinnamomum Zeylanicum. Int J Pharm Drug Anal. 2021;9(2):126–36.
  68. Basch E, Gabardi S, Ulbricht C. Bitter melon (Momordica charantia): a review of efficacy and safety. Am J Heal Pharm. 2003;60(4):356–9.
  69. Bagchi D, Swaroop A, Maheshwari A, Verma N, Tiwari K, Bagchi M, et al. A novel protodioscin-enriched fenugreek seed extract (Trigonella foenum-graecum, family Fabaceae) improves free testosterone level and sperm profile in healthy volunteers. Funct Foods Heal Dis. 2017;7(4):235–45.
  70. Mishra G, Singh P, Verma R, Kumar S, Srivastav S, Jha KK, et al. Traditional uses, phytochemistry and pharmacological properties of Moringa oleifera plant: An overview. Der Pharm Lett. 2011;3(2):141–64.
  71. Rathaur P, Raja W, Ramteke PW, John SA. Turmeric: The golden spice of life. Int J Pharm Sci Res. 2012;3(7):1987.
  72. Shutes J. Learn about Tarragon Essential Oil--Artemisia dracunculus.
  73. Upadhyay RK. Nutritional, therapeutic, and pharmaceutical potential of Hibiscus species. Int J Green Pharm. 2023;17(04).
  74. Rashid K, Hashimi M, Saleem S. Zaitoon/Olive (Olea europaea) as mentioned in The Holy Qur’an and Ahadith and its Ethno medicinal Importance.
  75. Ferreira Cuelho CH, de França Bonilha I, do Canto G, Palermo Manfron M. Recent advances in the bioactive properties of yerba mate. Rev Cuba Farm. 2015;49(2):375–83.
  76. Bjørklund G, Cruz-Martins N, Goh BH, Mykhailenko O, Lysiuk R, Shanaida M, et al. Medicinal Plant-derived Phytochemicals in Detoxification. Curr Pharm Des. 2024;30(13):988–1015.
  77. Kaur S, Sabharwal S, Anand N, Singh S, Baghel DS, Mittal A. An overview of Tulsi (Holy basil). Eur J Mol \& Clin Med. 2020;7(7):2833–9.
  78. Krupanidhi AM, Dabadi P, Sameera HR, Anusha MM, Deepika B V, Srinivas G, et al. Anti-Oxidant Activities Of Considerable Medicinal Plants: A Review Article. 2022;
  79. Feigel ML, Kennard A, Lannaman K. Herbalism for modern obstetrics. Clin Obstet Gynecol. 2021;64(3):611–34.
  80. Thakur M, Chandel M, Sharma A, Rani A, Sharma A, Kumar N. Indian Journal of Advances in Chemical Science. Indian J Adv Chem Sci. 2022;10(2):85–99.
  81. Gali-Muhtasib H, El-Najjar N, Schneider-Stock R. The medicinal potential of black seed (Nigella sativa) and its components. Adv Phytomedicine. 2006;2:133–53.
  82. Basch E, Ulbricht C, Hammerness P, Bevins A, Sollars D. Thyme (Thymus vulgaris L.), thymol. J Herb Pharmacother. 2004;4(1):49–67.
  83. Samac DA, Austin-Phillips S. Alfalfa (Medicago sativa L.). Agrobacterium Protoc. 2006;301–12.
  84. Vance AJ, Jones P, Strik BC. Foliar calcium applications do not improve quality or shelf life of strawberry, raspberry, blackberry, or blueberry fruit. HortScience. 2017;52(3):382–7.
  85. Stohs SJ, Miller H, Kaats GR. A review of the efficacy and safety of banaba (Lagerstroemia speciosa L.) and corosolic acid. Phyther Res. 2012;26(3):317–24.
  86. Al-Sereiti MR, Abu-Amer KM, Sena P. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. 1999;
  87. Wang S, Chen L, Yang H, Gu J, Wang J, Ren F. Regular intake of white kidney beans extract (Phaseolus vulgaris L.) induces weight loss compared to placebo in obese human subjects. Food Sci \& Nutr. 2020;8(3):1315–24.
  88. Jasuja ND, Choudhary J, Sharama P, Sharma N, Joshi SC. A review on bioactive compounds and medicinal uses of Commiphora mukul. J Plant Sci. 2012;7(4):113.
  89. Bundy R, Walker AF, Middleton RW, Wallis C, Simpson HCR. Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: a randomized, double blind placebo controlled trial. Phytomedicine. 2008;15(9):668–75.
  90. Bhandari PR, Kamdod MA. Emblica officinalis (Amla): A review of potential therapeutic applications. Int J Green Pharm. 2012;6(4).
  91. Tandel K, Deshpande S V, Soni AK, Choudhary Y. Acute Oral Toxicity Study of Nano Vijaysar (Pterocarpus Marsupium Roxb) Hydro Alcoholic Extract In Sprague Dawley Rats. 2022;
  92. Al-Jubori Y, Ahmed NTB, Albusaidi R, Madden J, Das S, Sirasanagandla SR. The efficacy of gum Arabic in managing diseases: A systematic review of evidence-based clinical trials. Biomolecules. 2023;13(1):138.
  93. Rivera JO, Loya AM, Ceballos R. Use of herbal medicines and implications for conventional drug therapy medical sciences. Altern Integ Med. 2013;2(6):1–6.
  94. Ameh SJ, Obodozie OO, Babalola PC, Gamaniel KS. Medical herbalism and herbal clinical research: a global perspective. Br J Pharm Res Sunday J. 2011;1(4):99.
  95. Wink M. Modes of action of herbal medicines and plant secondary metabolites. Medicines. 2015;2(3):251–86.
  96. Wen H, Jung H, Li X. Drug delivery approaches in addressing clinical pharmacology-related issues: opportunities and challenges. AAPS J. 2015;17:1327–40.
  97. Mukherjee PK. Quality control and evaluation of herbal drugs: Evaluating natural products and traditional medicine. Elsevier; 2019.
  98. Steingraber. Having faith: An ecologist’s journey to motherhood Sandra. Hachette UK; 2012.
  99. Yadav N, Singh Chandel S, Venkatachalam T, Fathima SN. Herbal Medicine Formulation, standardization, and Commercialization challenges and sustainable strategies for improvement. In: Herbal Medicine Phytochemistry: Applications and Trends. Springer; 2024. p. 1769–95.

Photo
Aman Gupta
Corresponding author

SMBT college of pharmacy Dhamangaon, Nashik.

Photo
Khushal Chaudhari
Co-author

SMBT college of pharmacy Dhamangaon, Nashik.

Aman Gupta*, Khushal Chaudhari, The Role of Medicinal Herbs in the Management of Metabolic Syndrome: A Comprehensive Review, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 4, 843-862-769 https://doi.org/10.5281/zenodo.15172906

More related articles
Biodegradable Sanitary Napkins An Innovative Appro...
Mounika K, Dr. K. B. Ilango, Baranitharan A. K., Dhivyatharshini ...
Review On Effectual Communication In Pharmacovigil...
Suraj Kumar Prajapati , Tarkeshwar P. Shukla , Pramod Mishra , ...
A Review On Anti-Diabetic Effect Of Neem (Azadirac...
Yogita Dhuri , Vishal Biswas, Shamili Singh, Shruti Rathore, Divy...
Insilico Studies On Herbal Phytoconstituents For The Treatment Of Covid-19: A Re...
Umarani Savita Bhimashankar, H. M. Mallikarjuna, Meghana H. E. , Muni Naga Gayathri S. , Naveenkumar...
Formulation And Evaluation of Guar Gum Gel for Wound Healing ...
Neha Rathod , Shivani Wankhade , Aditi Tikait, Dr. Swati Deshmukh, Ajip Rathod, ...
Related Articles
Alzheimer’s Disease: An Overview ...
G.V. Srivani, Thakur Vaishnavi, Kothagadi Veena, Poddutoori Manaswini, Sangem Varsha, S. K. Kovid, ...
Formulation And Evolution of Fast Dissolving Tablet Containing Nanoparticle Poor...
Rahul Kumar, Roop Singh Panthi, Rohit Kumar Dhakad, Rohit Kumar, Manoj Kumari More, ...
Development and Characterization of Antifungal Cream...
Ghadge Ishwari, Hyalij Shivani, Jadhav Shubham, Sonawane Mitesh, ...
Biodegradable Sanitary Napkins An Innovative Approach Towards Menstrual Hygiene ...
Mounika K, Dr. K. B. Ilango, Baranitharan A. K., Dhivyatharshini S., Gowtham K., Swetha V., Vijaykum...
More related articles
Biodegradable Sanitary Napkins An Innovative Approach Towards Menstrual Hygiene ...
Mounika K, Dr. K. B. Ilango, Baranitharan A. K., Dhivyatharshini S., Gowtham K., Swetha V., Vijaykum...
Review On Effectual Communication In Pharmacovigilance...
Suraj Kumar Prajapati , Tarkeshwar P. Shukla , Pramod Mishra , ...
A Review On Anti-Diabetic Effect Of Neem (Azadirachta Indica) Leaves...
Yogita Dhuri , Vishal Biswas, Shamili Singh, Shruti Rathore, Divyani Soni, ...
Biodegradable Sanitary Napkins An Innovative Approach Towards Menstrual Hygiene ...
Mounika K, Dr. K. B. Ilango, Baranitharan A. K., Dhivyatharshini S., Gowtham K., Swetha V., Vijaykum...
Review On Effectual Communication In Pharmacovigilance...
Suraj Kumar Prajapati , Tarkeshwar P. Shukla , Pramod Mishra , ...
A Review On Anti-Diabetic Effect Of Neem (Azadirachta Indica) Leaves...
Yogita Dhuri , Vishal Biswas, Shamili Singh, Shruti Rathore, Divyani Soni, ...